Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
Dominik Bogen(Broad Institute), Javed Khan(Kent State University), Xinyu Wen(National Institutes of Health), Jason M. Shohet(University of Massachusetts Chan Medical School), David O. Azorsa(Scottsdale Community College), Craig J. Thomas(National Institutes of Health), Lesley A. Mathews Griner(National Center for Advancing Translational Sciences), Hongling Liao(Broad Institute), Marielle E. Yohe(National Cancer Center), Jianbin He(National Institutes of Health), Eugen Buehler(University of Pennsylvania), Jun S. Wei(Center for Cancer Research), Shile Zhang(Guardant (United States)), Pinar Ormanoglu(National Institutes of Health), Scott E. Martin(National Institutes of Health), Arnulfo Mendoza(National Institutes of Health), Rajarshi Guha(Vertex Pharmaceuticals (United States)), Sabine Taschner‐Mandl(St Anna Children's Hospital), Peter F. Ambros(St Anna Children's Hospital), Young Song(University of British Columbia), Berkley E. Gryder(University School), Jonathan M. Keller(National Institutes of Health), Sivasish Sindri(National Institutes of Health), John Shern(National Cancer Institute), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition)
Cited by 70
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k